openPR Logo
Press release

Heart Pump Devices Market Share, Size, Drivers, Barriers, Landscape | Key Companies- Abbott Laboratories, Abiomed, Inc., Teleflex Incorporated, SynCardia Systems, LLC, and Others

04-08-2022 08:30 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Heart Pump Devices Market

Heart Pump Devices Market

DelveInsight's "Heart Pump Devices Market Insights, Competitive Landscape, and Market Forecast 2026" report delivers an in-depth understanding of the Heart Pump Devices and the historical and forecasted market size, and ongoing developments, emerging devices, and key companies operating in the global market.

Global Heart Pump Devices Market was valued at USD 2.37 billion in 2020, growing at a CAGR of 15.24% during the forecast period from 2021 to 2026, to reach USD 6.36 billion by 2026. The demand for Heart Pump Devices is primarily motivated by the increase in cardiovascular disease (CVDs) prevalence, the rise in the geriatric population, and various companies with products in their pipeline phase. Heart Pump devices were found to be extremely beneficial in heart failure cases in COVID-19 which further pushed the demand for these devices during the pandemic situation. Due to a scarcity of heart suppliers, cardiac pumps are an optimal solution that encourages Global market expansion. Factors such as the high cost of the pump and a low repayment scenario in developing countries are nevertheless projected to inhibit the growth of the market.

Read Full Research Report here @ https://www.delveinsight.com/report-store/heart-pump-device-market?utm_source=SatPR&utm_medium=pressrelease&utm_campaign=ypr

Heart Pump Devices: An Overview

Heart pump devices are utilized in patients that are suffering from heart issues such as a recent cardiac arrest. They carry out the normal functions of the heart by maintaining regular cardiac circulation and replacing the heart partially or completely. After receiving the blood from the lower chambers of the heart, it helps in transferring the blood to all the vital organs in the body.

Download Free Sample Report Now- https://www.delveinsight.com/sample-request/heart-pump-device-market?utm_source=SatPR&utm_medium=pressrelease&utm_campaign=ypr

Recent Developmental Activities in The Heart Pump Devices Market:

In August 2021, the United States Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed's Impella ECP expandable percutaneous Heart Pump. The designation means the FDA will prioritize Impella ECP's regulatory review processes including design iterations, clinical study protocols, and pre-market approval (PMA) application.

In February 2021, CARMAT received FDA approval to conduct an Early Feasibility Study (EFS) of its Total Artificial Heart in the US using BlueSync technology.

In December 2020, Abbott received FDA approval for the updated labeling for the HeartMate 3 Heart Pump to be used in pediatric patients with advanced refractory left ventricular heart failure.

Key Takes Away from the Heart Pump Devices Market Report Study

Market size analysis for current market size (2020), and market forecast for 5 years (2021-2026)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Heart Pump Devices market.
Top key product/services/technology developments, mergers, acquisitions, partnership, joint ventures happened for the last 3 years
Key companies dominating the Global Heart Pump Devices Market.
Various opportunities are available for the other competitor in the Heart Pump Devices Market space.
What are the top-performing segments in 2020? How these segments will perform in 2026.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Heart Pump Devices market growth in the coming future?

View Detailed Research Report Here @ https://www.delveinsight.com/report-store/heart-pump-device-market?utm_source=SatPR&utm_medium=pressrelease&utm_campaign=ypr

Heart Pump Devices Market Dynamics

As per the Centres for Disease Control and Prevention (CDC), in 2020, certain risk factors like coronary artery disease (CAD), heart attacks, diabetes, high blood pressure, and obesity increases the risk for heart failure. According to a report from the American Heart Association, 2020, the prevalence of heart failure continues to increase over time, with the aging of the population. An estimated 6.2 million American adults ≥20 years of age had heart failure between 2013 and 2016, compared with an estimated 5.7 million between 2009 and 2012

Heart Pump Devices Market Segment Analysis

Heart Pump Devices by Product (Ventricular Assist Devices- Left Ventricular Assist Devices (LVAD), Percutaneous Ventricular Assist Devices (PVAD), Biventricular Ventricular Assist Devices (BIVAD), Right Ventricular Assist Devices (RVAD), and Intra-Aortic Balloon Pumps, Total Artificial Hearts), Heart Pump Devices market by Type (Implanted Heart Pump Device, Extracorporeal Heart Pump Device), Heart Pump Devices market by Therapy (Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT)), Heart Pump Devices market by End-User (Hospitals, Cardiac Centres, Ambulatory Surgical Centres), and Heart Pump Devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Get access to a free copy of our latest sample report @ https://www.delveinsight.com/sample-request/heart-pump-device-market?utm_source=SatPR&utm_medium=pressrelease&utm_campaign=ypr

Heart Pump Devices Market By Product Segment
Ventricular Assist Devices is expected to hold the largest share and it is one of the fastest-growing segments in this market. It is primarily attributed to technological advancements, the scarcity of organ donors, and the increasing prevalence of heart failure globally. The technologically advanced features like the smaller pump size enable it to be implanted with minimal invasion to provide complete ventricular circulation assistance and reduced hemolysis by providing ample path for circulation, thus accounting for the largest shareholder in the market. There are various types of Ventricular Assist Devices available in the market, such as Left Ventricular Assist Devices, Percutaneous Ventricular Assist Devices, Biventricular Ventricular Assist Devices, and Right Ventricular Assist Devices. Additionally, assistance from government bodies, and favorable reimbursement scenarios, is expected to enhance the market potential in several countries. Hence, all the above-mentioned factors are expected to drive the segment growth of the Heart Pump Devices market

Heart Pump Device Market Companies

Abbott Laboratories
Abiomed, Inc.
Teleflex Incorporated
SynCardia Systems, LLC
St. Jude Medical Inc
CARMAT
CorWave SA
Medtronic Inc.
Terumo Heart, Inc.
Calon Cardio-Technology Ltd
NovaPump GmbH
Fresenius Medical Care AG & Co. KGaA
Angiodroid srl
Getinge AB, and Others

Request for More Info @ https://www.delveinsight.com/report-store/heart-pump-device-market?utm_source=SatPR&utm_medium=pressrelease&utm_campaign=ypr

Table of content
1. Report Introduction
2. Executive summary
3. Regulatory and Patent Analysis
4. Key factors analysis
5. Porter's Five Forces Analysis
6. COVID-19 Impact Analysis
7. Market layout
8. Global Company Share Analysis - Key 3-5 Companies
9. Company and Product Profiles
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight

Consult with our Business Expert @ https://www.delveinsight.com/sample-request/heart-pump-device-market?utm_source=SatPR&utm_medium=pressrelease&utm_campaign=ypr

About Us
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Contact Us
Yash
info@delveinsight.com
https://www.delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Heart Pump Devices Market Share, Size, Drivers, Barriers, Landscape | Key Companies- Abbott Laboratories, Abiomed, Inc., Teleflex Incorporated, SynCardia Systems, LLC, and Others here

News-ID: 2598189 • Views:

More Releases from DelveInsight Business Research

Vitiligo Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Vitiligo Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA App …
The "Vitiligo Pipeline Insight, 2025" report by DelveInsight delivers an in-depth view of the current clinical development scenario along with the future growth trajectory of the Vitiligo Market. As per DelveInsight's evaluation, the global Vitiligo treatment pipeline features 20+ leading companies actively engaged in developing 20+ therapeutic candidates. The analysis covers Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and developmental updates. The Vitiligo Pipeline report offers extensive commercial and clinical
Myelodysplastic Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Myelodysplastic Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Th …
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2025" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Myelodysplastic Syndrome Pipeline Report • DelveInsight's Myelodysplastic Syndrome
Fibromyalgia Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Fibromyalgia Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA …
According to DelveInsight, the global Fibromyalgia pipeline features more than eight key companies actively developing over ten treatment candidates. The analysis encompasses ongoing clinical trials, therapeutic mechanisms of action, routes of administration, and recent developments within the Fibromyalgia treatment landscape. The Fibromyalgia Pipeline 2025 report provides an exhaustive evaluation of pipeline products, ranging from preclinical stages to marketed therapies. It includes comprehensive details on each drug's mechanism of action, clinical trial
Chronic Wounds Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Chronic Wounds Competitive Landscape 2025: Clinical Trial Analysis, Therapies, F …
As per DelveInsight's assessment, globally, Chronic Wounds pipeline constitutes 7+ key companies continuously working towards developing 8+ Chronic Wounds treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Chronic Wounds Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Chronic Wounds Market. The Chronic Wounds Pipeline report embraces in-depth commercial and clinical assessment

All 5 Releases


More Releases for Device

Medical Device Regulatory Affairs Market Medical Device Regulatory Affairs Marke …
"Medical Device Regulatory Affairs Market" in terms of revenue was estimated to be worth $ 6.7 billion in 2024 and is poised to reach $ 18.3 billion by 2034, growing at a CAGR of 10.8% from 2025 to 2034 according to a new report by InsightAce Analytic. Request For Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1913 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global medical device regulatory
Surge In Wireless Device Usage Boosts Wireless Audio Device Market Driving Marke …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. How Large Will the Wireless Audio Device Market Size By 2025? In recent years, there has been remarkable growth in the wireless audio device market size. The market, which is projected to expand from $41.85 billion in 2024 to $52.37 billion in 2025, boasts a compound annual growth rate (CAGR) of 25.1%. Factors contributing
Anti-snoring Device Market - Quiet Nights, Restful Sleep: Anti-snoring Device In …
Newark, New Castle, USA: The "Anti-snoring Device Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Anti-snoring Device Market: https://www.growthplusreports.com/report/antisnoring-device-market/8931 This latest report researches the industry structure, sales, revenue,
Global Watch Clock Measuring Device Market | Watch Clock Measuring Device Indust …
Watch, clock and measuring device market comprises of the sales of watch, clock, measuring device & related services to measure the time and physical quantity. Watch is portable timepiece, which is worn by people around the wrist, attached by a strap. Clock is a device used to measure and indicate time, using the pointers moving over a dial. Measuring device is an instrument used for measuring the various parameters in
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations. Request for Sample of This Research Report @ https://bit.ly/2xjOKpC Top Key Player:- Abbott Laboratories Braun Melsungen AG Boston Scientific Corporation R. Brad, Inc. Cardinal Health, Inc. Medtronic plc. Cook Medical, Inc. Teruma Corporation Jude Medical, Inc. The Spectranetics Corporation Volcano Corporation Peripheral vascular disorder (PVD) is a blood circulation disorder
Medical Device Technologies Market - The Evolution of Medical Device Technologie …
The global medical device technologies market is anticipated to be boosted by various well-known players in the market. Some of these players that are dealing with the manufacturing of in vitro diagnostic devices hold a significant share in the global market. Whereas, the small market players are emerging from several developing nations, looking to set their foot in the market. Such measures are foreseen to change the market scenario in